Rebuilt cancer drug strikes tumours hard, spares healthy cells
Newsweek - 04-Nov-2025SNA-engineered 5FU killed AML cells up to 20,000× more effectively with no detected toxicity
Join the club for FREE to access the whole archive and other member benefits.
SNA-engineered 5FU killed AML cells up to 20,000× more effectively with no detected toxicity
Trial of 6,000 patients aims to identify cancer early using unique breath compounds
NHS trial uses AI to analyse MRI scans in minutes, speeding up diagnosis for over 58,000 men yearly
New CAR T therapy eradicated large prostate tumours in 4 of 5 treated mice
The treatment is quick, easy, and gives hope to many patients
Galleri detected cancer in 1% of 25,000 adults, with 62% confirmed and over half at early stages
Targeted pill shows strong tumour reduction and better quality of life for HER2-mutant patients
LED treatment killed 92% of skin cancer and 50% of colorectal cancer cells safely
New GlyTR protein directs T cells to destroy diverse tumours while sparing healthy cells
Blocking SPP1 protein halted tumour growth and extended survival in lab and animal studies
Low-dose aspirin after surgery shows strong benefit for patients with specific tumour mutations
Median survival rose from 2.4 to 4.5 years; five-year survival in over-80s up five-fold
Research shows turtles’ unique biology helps protect them from tumours despite long lifespans
Engineered NKT cells attack tumours and reshape defences, offering new hope for kidney cancer
High-speed data analysis could unlock hidden patterns to design new cancer vaccines
Real-time tissue scanning may cut radiotherapy need and preserve quality of life
Study finds pancreatic, lung, and stomach cancers see little progress in long-term survival
Jab targeting KRAS mutation kept some patients cancer-free for over 15 months
New dual-bacteria therapy shows potent, safe cancer-killing power in immunocompromised models
Certified AI app offers safe, reliable skin cancer risk checks via smartphone photos
Doctors can now tailor treatments more precisely with these insights
AI flagged 40K+ scans/month, avoided 1,400 CTs, and helped detect 2,000 lung cancers early
Without changes, liver cancer cases and deaths could nearly double by 2050
Digital cells forecast disease and drug response
RP1 shrinks deep skin tumours and may soon win FDA approval as a new melanoma treatment